πŸ‡»πŸ‡ͺ Country Profile

Venezuela

Pharmaceutical products reaching Venezuela

πŸ‡»πŸ‡ͺ $90.0M
All data from DGCIS India export records (fiscal year, April–March).
$90.0M
Scale
Venezuela's patients receive $90.0M in Indian pharmaceutical products annually β€” almost entirely finished medicines ready for dispensing.
93%
Medicine
Overwhelmingly finished medicines β€” drug formulations account for 93% of shipments.
Context
Part of India's pharmaceutical supply network across Americas.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Venezuela β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $83.6M (92.6%) Medicine Ingredients $2.8M (3.1%) Vaccines $2.6M (2.8%) Surgical & Hospital Supplies $1.2M (1.4%) Traditional & Herbal $0.06M (0.1%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Venezuela Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Venezuela: $12.7M across 31 filings (2011-2017).